Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
15 4월 2025 - 10:20PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment
No. )
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐ |
Preliminary
Proxy Statement |
☐ |
Confidential,
For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ |
Definitive
Proxy Statement |
☒ |
Definitive
Additional Materials |
☐ |
Soliciting
Material Under §240.14a-12 |
ENVERIC
BIOSCIENCES, INC.
(Name
of Registrant as Specified in Its Charter)
(Name
of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment
of Filing Fee (Check all boxes that apply):
|
☒ |
No
fee required. |
|
|
|
|
☐ |
Fee
paid previously with preliminary materials |
|
|
|
|
☐ |
Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Enveric Biosciences (NASDAQ:ENVB)
과거 데이터 주식 차트
부터 6월(6) 2025 으로 7월(7) 2025
Enveric Biosciences (NASDAQ:ENVB)
과거 데이터 주식 차트
부터 7월(7) 2024 으로 7월(7) 2025